First-Line Therapy for Advanced Renal Cell Carcinoma: Score-Matched Analysis of Dual Combination Immunotherapy versus Combination of Tyrosine Kinase Inhibitors and Immunotherapy in the TOURS Multicenter Study.
Saved in:
| Title: | First-Line Therapy for Advanced Renal Cell Carcinoma: Score-Matched Analysis of Dual Combination Immunotherapy versus Combination of Tyrosine Kinase Inhibitors and Immunotherapy in the TOURS Multicenter Study. |
|---|---|
| Authors: | Watanabe H; Department of Urology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Chuo-ku, Hamamatsu, 431-3192, Japan. urohiro@hama-med.ac.jp., Nakane K; Department of Urology, Gifu University Graduate School of Medicine, Gifu, Japan., Nukaya T; Department of Urology, Fujita Health University School of Medicine, Toyoake, Japan., Naiki T; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan., Yasui T; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan., Takahara K; Department of Urology, Fujita Health University School of Medicine, Toyoake, Japan., Koie T; Department of Urology, Gifu University Graduate School of Medicine, Gifu, Japan., Inamoto T; Department of Urology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Chuo-ku, Hamamatsu, 431-3192, Japan., Miyake H; Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan. |
| Source: | Targeted oncology [Target Oncol] 2026 May; Vol. 21 (3), pp. 399-410. Date of Electronic Publication: 2026 Apr 22. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42020851 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: First-Line Therapy for Advanced Renal Cell Carcinoma: Score-Matched Analysis of Dual Combination Immunotherapy versus Combination of Tyrosine Kinase Inhibitors and Immunotherapy in the TOURS Multicenter Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Watanabe+H%22">Watanabe H</searchLink>; Department of Urology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Chuo-ku, Hamamatsu, 431-3192, Japan. urohiro@hama-med.ac.jp.<br /><searchLink fieldCode="AU" term="%22Nakane+K%22">Nakane K</searchLink>; Department of Urology, Gifu University Graduate School of Medicine, Gifu, Japan.<br /><searchLink fieldCode="AU" term="%22Nukaya+T%22">Nukaya T</searchLink>; Department of Urology, Fujita Health University School of Medicine, Toyoake, Japan.<br /><searchLink fieldCode="AU" term="%22Naiki+T%22">Naiki T</searchLink>; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Yasui+T%22">Yasui T</searchLink>; Department of Nephro-urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Takahara+K%22">Takahara K</searchLink>; Department of Urology, Fujita Health University School of Medicine, Toyoake, Japan.<br /><searchLink fieldCode="AU" term="%22Koie+T%22">Koie T</searchLink>; Department of Urology, Gifu University Graduate School of Medicine, Gifu, Japan.<br /><searchLink fieldCode="AU" term="%22Inamoto+T%22">Inamoto T</searchLink>; Department of Urology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Chuo-ku, Hamamatsu, 431-3192, Japan.<br /><searchLink fieldCode="AU" term="%22Miyake+H%22">Miyake H</searchLink>; Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101270595%22">Targeted oncology</searchLink> [Target Oncol] 2026 May; Vol. 21 (3), pp. 399-410. <i>Date of Electronic Publication: </i>2026 Apr 22. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag+France%22">Springer-Verlag France </searchLink><i>Country of Publication: </i>France <i>NLM ID: </i>101270595 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1776-260X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217762596%22">17762596 </searchLink><i>NLM ISO Abbreviation: </i>Target Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42020851 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s11523-026-01219-y Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 399 Titles: – TitleFull: First-Line Therapy for Advanced Renal Cell Carcinoma: Score-Matched Analysis of Dual Combination Immunotherapy versus Combination of Tyrosine Kinase Inhibitors and Immunotherapy in the TOURS Multicenter Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Watanabe H – PersonEntity: Name: NameFull: Nakane K – PersonEntity: Name: NameFull: Nukaya T – PersonEntity: Name: NameFull: Naiki T – PersonEntity: Name: NameFull: Yasui T – PersonEntity: Name: NameFull: Takahara K – PersonEntity: Name: NameFull: Koie T – PersonEntity: Name: NameFull: Inamoto T – PersonEntity: Name: NameFull: Miyake H IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1776-260X Numbering: – Type: volume Value: 21 – Type: issue Value: 3 Titles: – TitleFull: Targeted oncology Type: main |
| ResultId | 1 |
